13 companies had the people running the company buying on the open market in filings dated Oct 20, 2020, about $47.1 million combined. The biggest was TARS (Tarsus Pharmaceuticals, Inc.), where Frazier Life Sciences IX, L.P. led about $14.7 million of buying.
Five of the buys came from a CEO or CFO. Cluster buying (3+ insiders) is running at 67 companies this month. One buy doesn't make a thesis, but it's a good place to start digging.